Selected EMA news, January 2025

New medicines recommended for approval

• Rytelo (imetelstat sodium) – orphan
  Treatment of anemia (low levels of red blood cells)
• Zefylti (filgrastim) – biosimilar
  Treatment of neutropenia (low level of white blood cells) in patients having chemotherapy or a bone marrow transplant

New information on approved medicines

• Blincyto (blinatumomab) – extension of indication
  Treatment of B-precursor acute lymphoblastic leukemia (a type of blood cancer)